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Abstract
Schizophrenia encompasses a wide variety of cognitive dysfunctions, a number of which can be understood as deficits of
inhibition. To date, no research has examined ‘conditioned inhibition’ in schizophrenia - the ability of a stimulus that signals
the absence of an expected outcome to counteract the conditioned response produced by a signal for that outcome (a
conditioned excitor). A computer-based task was used to measure conditioned excitation and inhibition in the same
discrimination procedure, in 25 patients with a confirmed diagnosis of schizophrenia and a community-based comparison
sample. Conditioned inhibition was measured by a ratio score, which compared the degree to which the inhibitory stimulus
and a neutral control stimulus reduced conditioned responding to the excitatory cue: the lower the ratio, the greater the
inhibitory learning. At test the ratios were 0.45 and 0.39 for patient and control groups respectively, and the relevant
interaction term of the ANOVA confirmed that the degree of inhibition was reduced in the patient group, with an effect size
of r= 0.28. These results demonstrate for the first time that inhibitory learning is impaired in schizophrenia. Such an
impairment provides an attractive framework for the interpretation of the positive symptoms of schizophrenia. However, we
were unable to demonstrate any relationship between the level of conditioned inhibition and medication. Similarly, in the
present study it must be emphasised that the available data did not demonstrate any relationship between individual
variation in inhibitory learning and the level of positive symptoms as measured by the PANSS. In fact inhibitory learning
impairment was relatively greater in participants with a predominantly negative symptom profile and their excitatory
learning was also reduced. Accordingly the next step will be to investigate such relationships in a larger sample with a priori
defined sub-groups displaying predominantly positive versus predominantly negative symptoms.
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Introduction
Cognitive dysfunction is a definitive aspect of schizophrenia
[1,2], and the information-processing abnormalities associated
with this condition are diverse. However, one emergent theme is
that many of these impairments can be broadly understood as
varieties of inhibition deficit [3,4,5,6,7,8,9,10,11,12]. Yet it would
be simplistic to describe schizophrenia as a deficit in inhibition,
because the ‘inhibitory’ processes supposedly affected are very
diverse. For example, a disruption in prepulse inhibition [13] - the
reduction in the unlearned startle response produced by a weaker
version of the later presented startle stimulus - has been reported in
schizophrenic populations [11,14,15,16,17,18,19]. There have
also been reports of a deficit in latent inhibition (LI) [20], which is
the slowed acquisition of a learned (or conditioned) response to a
conditioned stimulus (CS), which signals a stimulus of intrinsic
affective value (an unconditioned stimulus, or US). LI results if the
conditioned stimulus is pre-exposed prior to the conditioning
treatment [3,9,21,22,23,24].
Another example of inhibition of learned responding is
conditioned inhibition (CI). A conditioned inhibitor is a stimulus
which predicts that an otherwise expected outcome will not occur
[25,26]. For example, if stimulus A signals the US when presented
alone, but after a compound of A with a further stimulus, B, the
US is omitted (AB2), B is termed a conditioned inhibitor [25].
This is evident in B’s resultant ability to suppress the conditioned
responding produced by other signals for that same US. CS pre-
exposure retards acquisition of CI just as it retards CSRUS (or
excitatory) learning [27,28], indicating the distinction between CI
and LI. Indeed LI has often been interpreted as a loss of attention
to the pre-exposed cue which disrupts both excitatory and
inhibitory learning [29]. There are reasons for expecting that CI
will also be disrupted in schizophrenia: CI is reduced in
participants with high schizotypy [30], and in animal studies the
dopaminergic system has been identified as a key substrate that
mediates CI [31,32]. This was the starting point for the present
investigation.
A deficit in CI could help explain some of the cognitive
symptoms of schizophrenia. Paradigms such as LI and CI were
developed in studies with animals, and are grounded in classical
conditioning theory, which describes learning about signals for
motivationally significant outcomes that elicit involuntary, un-
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learned responses comprising behavioural, cognitive and affective
components. Some of these components will also be present in the
conditioned response to the CS that signals that outcome. These
conditioned responses are involuntary, and so CI may be
understood without recourse to higher cognitive constructs. Yet
an inhibitor can be regarded as potentially inhibiting not only the
behavioural responses elicited by the CS, but also the affective and
cognitive responses that are associated with it - meaning that it can
affect behaviour at a number of levels. Moreover, although the
behavioural changes directly attributable to the CS or the inhibitor
follow more or less immediately [33], the internal state associated
with schizophrenia might conceivably act as an internal context, as
has been proposed for depression [34,35], in which a failure to
learn about conditioned inhibitors would be embedded. A failure
to inhibit various associations could thus be activated by this
internal state, and in this manner contribute to symptoms of
schizophrenia, such as sensory flooding and delusions. For
example, in a healthy subject the chance pairing of a mundane
object with an emotionally significant event will not influence
subsequent behaviour, because on subsequent occasions they will
learn that the expected motivationally significant event no longer
occurs - via the inhibitory learning process. If this learning is
impaired in the schizophrenia sufferer, then the events of everyday
life will remain significant and continue to demand attention,
resulting in aberrant behaviour. Similarly, patients experience
delusions of reference when they perceive stimuli provided by
exposure to the media or being in some public place as pertaining
specifically to them. Recent functional magnetic resonance
imaging studies show that both patients with schizophrenia and
healthy controls with experimentally induced self-referential
ideation (using individually specific information taken from an
interview conducted some weeks earlier), display characteristic
patterns of brain activation in cortical midline structures, as well as
in interconnected midbrain dopaminergic regions implicated in
schizophrenia and CI. In contrast, normal participants presented
with nonpersonalised experimental materials are able to inhibit
associations with their current circumstances and interests [12].
In summary, there are both empirical and theoretical grounds
for hypothesising that conditioned inhibitory learning might be
impaired in participants with schizophrenia. The present study
examined whether this was in fact the case.
Methods
Objectives
The primary objective of the present study was to test the
hypothesis that CI would be impaired in participants with
schizophrenia. We also sought to establish whether the level of
CI shown was systematically related to symptom severity.
Participants
The experiment was conducted on 25 patients from three
different adult mental health residential units in the city of
Nottingham, UK. Diagnoses of schizophrenia met the Interna-
tional Classification of Diseases [36] criteria for schizophrenia, in
the absence of comorbid mental conditions. Patients from two of
the three units had a formal psychiatric assessment of symptom
severity using the KGV scale [37]. All 25 patient participants
completed the computer task. Twenty of these also completed the
Positive and Negative Syndrome Scale (PANSS) interview [38] to
assess their current (or recent) symptoms, 11 on the same day as
the CI task. In total 9 participants did not complete the PANSS on
the same day as the behavioural test but were willing to do so.
They were interviewed at the earliest mutually convenient which
turned out to be within 3–7 weeks. The remaining 5 participants
were unwilling to complete the PANSS interview in addition to the
behavioural test. Table 1 shows the summary PANSS scores.
Participants were under a variety of antipsychotic medication
regimes. Calculation of the chlorpromazine (CPZ) equivalent was
based on: 100 mg/day CPZ=5 mg/day olanzapine, 100 mg/day
clozapine, 200 mg/day sulpiride, 1 mg/day risperidone
[39,40,41,42,43].
The controls were a community-based sample of 25 participants
living in the same county, matched as far as possible on age,
ethnicity and educational status (see Table 2). None reported or
showed any indication of mental illness or substance abuse. All
were tested under comparable, quiet environmental conditions by
ZH. All 25 control participants completed the computer task.
Ethics
The study was approved by UK NHS Research Ethics
(Derbyshire Research Ethics Committee, reference No. 08/
H0401/65, September 2008), and by the University of Notting-
ham, School of Psychology Ethics Committee. As an inconve-
nience allowance, control participants received £5, and schizo-
phrenic participants £10. Before the task, each participant was
required to read the information sheet and sign a consent form.
Patients’ capacity to give consent was based on the judgement of
the clinical staff who had duty of care at their residential unit on
that day. If a potential participant was deemed unable to give
informed consent, they were not approached to take part in the
study.
Design
The design of the experiment is shown in Table 3. There were
three stages: (1) pre-experimental, (2) excitatory and inhibitory
training, and (3) test [44].
In the pre-experimental stage participants rated the neutral
stimuli and stimulus compounds (A, C, AZ, AP, BX, CY, CP and
CX) which were to serve as CSs in the subsequent stages, to allow
control for preexisting biases.
The training stage comprised excitatory training, followed by
inhibitory training. During the excitatory training phase four
individual CSs were paired with either reinforcement (a positive
picture, on A+ and C+ trials), or nonreinforcement (a neutral
picture, on U2 and V2 trials); the difference in learning about
reinforced and nonreinforced cues provided a measure of simple
excitatory learning.
During the second, inhibitory training phase, the CS compound
AZ signalled reinforcement (AZ+), whereas a second compound,
AP, signalled nonreinforcement (AP2); P thus signalled the
absence of the reinforcement predicted by A, and established P
as a conditioned inhibitor. Two additional compounds, CY and
BX, were reinforced and non-reinforced respectively (CY+, BX2);
X was the control stimulus for the test that followed.
The final, test phase was designed to confirm that P was a
conditioned inhibitor, by examining whether it would suppress
responding to the excitatory C [26]. X, the control stimulus,
differed from P only in that it had not signalled the absence of
reinforcement, and so should not have acquired inhibitory
properties. The critical comparison was thus between CP and
CX. If CP was rated less positive than CX, this suggested that P
was more effective in counteracting the ability of C to predict a
nice picture, and was thus evidence that P was inhibitory.
Stimuli
Nine Lego block pictures were used as CSs. P and X were
counterbalanced, as were A and B, and C and V (see Table 4).
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The USs were images from the International Affective Picture
System (IAPS) [45], a set of images standardised on the dimensions
of valence and arousal from 1 to 9, 1 representing a low and 9 a
high rating. The USs comprised 10 positive and 10 neutral
pictures with mean valences (SD, range) positive = 7.89 (0.27,
7.56–8.28) and neutral = 4.94 (0.08, 4.86–5.08); mean arousal
ratings (SD, range) positive = 4.86 (1.03, 3.08–6.73) and neu-
tral = 2.79 (0.54, 1.72–3.46). The codes of the IAPS images which
served as the positive USs were 1440, 1610, 1750, 1920, 8370,
8380, 2040, 2154, 2160 and 8496; those serving as negative
pictures were images 2393, 2396, 2512, 2890, 7006, 7055, 7175,
7185, 7187 and 6150 [44]. Positive USs were presented on
‘reinforced’ trials and neutral USs on ‘non-reinforced’ trials. The
measure of conditioning was a rating of what kind of picture the
participant predicted would follow presentation of the CS, ranging
from 1 (neutral) to 9 (positive), with a rating of 5 (‘not sure’, see
Figure 1) intended to reflect uncertainty as to the following
outcome; an average was calculated for each particular CS or CS
combination in each phase.
Statistical Analysis
A summary measure of excitatory learning was provided by the
ratio of the mean ratings of the reinforced C and nonreinforced V,
i.e. C/(C+V) from all trials of the excitatory training stage; greater
C/(C+V) scores indicated greater excitatory learning. An a priori
exclusion criterion (C/(C+V)=,.5) was applied to excitatory
training performance, as a result of which nine participants (five
patients and four controls) were excluded as being unable to learn
the basic task. A summary measure of CI was provided by the ratio
of the mean ratings of CP and CX, i.e. CP/(CP+CX); the lower
this ratio, the greater the inhibitory learning. Prior to statistical
analysis, the ratio measures were subjected to an arcsine root
transformation [46]. Statistical analyses were by mixed design
analysis of variance (ANOVA). Significant interactions were
explored with simple main effects analysis using the pooled error
term for between subjects contrasts. Planned comparisons of the
assessment score data were by t-test. The measure of effect size
given for mixed design ANOVAs was Pearson’s correlation
coefficient, r; following Field [47] r was calculated only for main
effects with two levels and specific contrasts. Correlational analyses
(Pearson’s) were used to examine the relationship between learning
scores and (1) symptom profile (measured by PANSS) and (2)
antipsychotic medication dosage. For r values suggesting correla-
tions at or close to statistical reliability we also report the
coefficient of determination (r2) in order to consider the proportion
of the variance explained. All statistics were performed with SPSS,
apart from simple main effects analysis which was performed with
Experstat.
Procedure
The task instructions were that a cat ‘Mogwai’ would bring
participants either a positive picture or a neutral, boring picture,
depending on what kind of Lego blocks she found in her basket.
Participants were told that they would be asked to guess, or
predict, what kind of picture would follow presentation of the Lego
blocks, using a rating scale from 1 (neutral) to 9 (positive), with a
rating of 5 (‘not sure’, see Figure 1) intended to reflect uncertainty
as to the following outcome. Reminder instructions were presented
on-screen at each stage of the procedure.
Before the first phase participants were shown some represen-
tative US pictures, and also CS pictures with the rating scale, on
4.566 cm cards, and the rating procedure was explained; these
pictures were not used in the experiment. Participants were told
that the session, comprising three stages, would last about
20 minutes, and they were welcomed to ask questions.
Pre-experimental stage
Participants were first instructed that they must guess what kind
of picture the cat might bring based on the Lego blocks presented,
although no pictures would follow. A CS was presented, after
which participants clicked on a number button to guess the US
valence; the next CS presentation followed immediately. There
Table 1. Summary details of the patients’ PANSS scores.
PANSS Positive PANSS Negative PANSS General PANSS Total
Mean (SD) 14.10 (4.45) 18.65 (8.36) 28.10 (5.86) 60.85 (12.62)
Range 7–21 8–36 16–37 36–79
Note: Mean and standard deviation (SD) of patients’ (n = 20) scores on the different sub-scales of the PANSS, together with the minimum and maximum (Range) of
scores on each sub-scale.
doi:10.1371/journal.pone.0042175.t001
Table 2. Summary details of the final sample of participants.
Schizophrenic patients (n =25) Control participants (n=25)
Age (years) 30.64 31.20
Age range (years) 20–41 19–48
Gender (N =male/female) 18/7 18/7
Education range (years) 11–15* 11–14*
Ethnicity 24 White and 1 Black 24 White and 1 Black
Note: * In the UK, the number of years in education required to achieve A level is 14. The patient records did not give full details of level of education, so patient
participants were asked whether they had attended university (just one who had dropped out in year 1, hence no undergraduate participants were included in the
matched control group). Based on the available data (N = 25 for controls and N=21 for patients) the median level of education was 12 years for both patient and control
participants, and on a Mann-Whitney U test there was no significant difference between the patient and control groups, p= 0.088.
doi:10.1371/journal.pone.0042175.t002
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were 16 stimulus presentations, two of each of the following: A, C,
AZ, AP, BX, CY, CP and CX (see Table 3). Throughout the
experiment CS presentations were counterbalanced for right/left
position on the screen, and the various trial types were presented
in a semi-random sequence (constrained by the total number of
trials of a particular type in each stage).
Training stages
At the start of the first training stage the participants were
instructed that, as before, they must predict what kind of picture
the cat might bring, based on the Lego block that was presented,
and that they would then be shown the picture that the cat had
brought. The excitatory training stage comprised 6 training blocks,
each with two of the four kinds of trial, A+, U2, V2 and C+.
Table 3. The design of the experiment.
Pre-experimental stage (a) Excitatory training stage (b) Inhibitory training stage Test
CSs No. trials CSs & USs No. trials CSs & USs No. trials CSs No. trials
A 2 A+ 12 AZ+ 8 A 2
C 2 U2 12 AP2 12 C 2
AZ 2 V2 12 BX2 12 AZ 2
AP 2 C+ 12 CY+ 8 AP 2
BX 2 BX 2
CY 2 CY 2
CP 2 CP 4
CX 2 CX 4
Note: Letters denote the 9 conditioned stimuli (pictures of Lego blocks); the identities of which were counterbalanced (see Table 4). With respect to US presentations
that immediately followed CS presentations during the training stages, ‘+’ represents a positive IAPS picture and ‘2’ a neutral IAPS picture; see text for the identities of
the IAPS pictures which served as positive and neutral stimuli.
doi:10.1371/journal.pone.0042175.t003
Figure 1. The rating scale and an example of a CS compound (top left panel), a positive US (top right panel), and the cat Mogwai
(lower panel).
doi:10.1371/journal.pone.0042175.g001
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After the participant had rated the valence of the predicted US, a
US, randomly selected from the pool of positive or neutral USs as
appropriate, was presented for 1 s. The next trial followed after a
1 s gap, during which a picture of the cat Mogwai (around
666 cm) was presented on a white background. The inhibitory
training stage followed directly after this stage and comprised 4
kinds of trial (AZ+, AP2, BX2 and CY+) presented in two blocks.
Each block comprised 4 presentations of each reinforced
compound and 6 of each non-reinforced compound.
Test stage
The test stage was identical to the pre-experimental stage,
except that there were four presentations of each of the test
compounds CP and CX.
Throughout the experiment, whenever participants asked
questions or made comments they were asked to try to focus on
the task and to try to remember or guess which outcome (positive
or neutral picture) was predicted by the Lego blocks.
Results
Pre-experimental stage
The mean ratings of CP and CX were, respectively, 4.9 and
4.76 for the patient group and 5.28 and 4.42 for the control
participants. ANOVA with stimulus (CP v. CX) and group
(schizophrenic patients v. controls) revealed no pre-existing
differences in ratings of the two critical compounds CP and CX,
F(1,48) = 1.73, p=0.19, or any effect of, or interaction with, group,
Fs,1.
Training stage 1: Excitatory training
The results of the initial training stage provided a measure of
excitatory learning in the two groups; although both groups clearly
learned the task, the patient group appeared to respond less on
reinforced, and more on nonreinforced trials, than the control
participants (Figure 2). ANOVA with group, discrimination (A+
versus U2, C+ versus V2), reinforcement and training block as
factors revealed a significant interaction between reinforcement
and diagnostic group, F(1,48) = 7.73, p=0.008, r=0.37; although
both groups learned the discrimination, F(1,48) = 96.41 and 31.68
for control and patient groups respectively, ps,0.001, they differed
on both reinforced, F(1,96) = 4.40, p=0.04, and nonreinforced
trials, F(1,96) = 7.95, p=0.006. This suggests some degree of
learning impairment in the patient group. This was confirmed by
an analysis of the summary measure of excitation, C/C+V; the
mean score was .64 for the patient group and .72 for the control
group, and these values differed significantly, F(1,48) = 5.25
p= .026 r= .314. For additional details please see Supporting
Information S1.
Training stage 2: Inhibitory training
During this stage participants were trained on the key
discrimination between AZ+ and AP2, which was designed to
turn P into a conditioned inhibitor; they were also required to
discriminate between CY+ and BX2. Both groups learned these
discriminations, but again the patient group showed slightly poorer
performance (Figure 3).
ANOVA with group (patient v. control), discrimination (AZ+ v.
AP2 and CY+ v. BX2), reinforcement (reinforced or not) and
training block (1–2) as factors revealed a significant interaction
between reinforcement and group, F(1,48) = 11.08, p=0.002
r=0.43. Although both groups learned the two tasks,
F(1,48) = 92.84 and 24.29 for patient and control groups
respectively, ps,0.001, the groups differed on both reinforced
and non-reinforced trials, F(1,96) = 9.99, p=0.002, and
F(1,96) = 5.01, p=0.03. For additional details please see Support-
ing Information S1.
Test stage
It is clear from Figure 4 that, although during the pre-
experimental stage both groups rated CP and CX similarly, during
the test phase CP was rated lower than CX, suggesting P had
become inhibitory. Critically, this effect seemed more marked in
the control participants. To evaluate this the ratio CP/(CP+CX)
was computed for both pre-experimental and test stages for each
group. The resulting scores for the pre-experimental stage were
0.51 for the patient group and 0.56 for the controls; neither score
differed from 0.5, p=0.71 and 0.08 respectively, confirming that
there were no pre-existing biases in responding to CX and CP. At
test the ratios were 0.45 and 0.39 for patient and control groups
respectively, and both differed from 0.5, p=0.015 and 0.007
respectively, confirming that P had acquired inhibitory properties
in both groups. Nonetheless the degree of inhibition appeared
reduced in the patient group, and ANOVA with group and stage
(pre-experimental and test) as factors confirmed this, revealing a
significant interaction, F(1,48) = 4.05, p=0.049, r=0.28; the effect
of stage was significant in the control group, F(1,48) = 18.54,
p=0.001, but not in the patients, F(1,48) = 2.13, p=0.15.
Table 4. The identity of the various Lego blocks (I–IX) that served as the experimental stimuli in the eight counterbalanced
subgroups.
Counterbalanced Group Conditioned stimuli and identity of Lego block
A B C P X Y Z U V
1 I II III IV V VI VII VIII IX
2 I II III V IV VI VII VIII IX
3 II I III IV V VI VII VIII IX
4 II I III V IV VI VII VIII IX
5 I II IX IV V VI VII VIII III
6 I II IX V IV VI VII VIII III
7 II I IX IV V VI VII VIII III
8 II I IX V IV VI VII VIII III
doi:10.1371/journal.pone.0042175.t004
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ANOVA comparing group mean ratings of CX in both stages
revealed no significant effect of group, stage, or interaction
between the two factors, F,1, F(1,48) = 2.47, p=0.12, and F,1,
respectively, confirming that there were no group differences in
responding to CX, the baseline against which the effect of P was
evaluated.
Differences by symptom profile
The summary measures of excitation (C/(C+V)) and inhibition
(CP/(CP+CX)) did not correlate with the PANSS General score,
r(20) =20.14, p=0.57, and r(20) =20.29, p=0.22, respectively.
However, the summary inhibition measure correlated significantly
with the PANSS Negative symptom scores, r(20) = 0.45, p=0.05,
accounting for approximately 20% of the variance, r2=0.20, while
the corresponding relationship with the summary excitatory
measure was marginal but similar in magnitude, r(20) =20.41,
p=0.07, accounting for approximately 17% of the variance,
r2=0.17. In contrast the PANSS Positive symptom scores
correlated neither with inhibitory, r(20) =20.16, p=0.50, nor
excitatory summary measures, r(20) =20.05, p=0.83. Therefore
the relationship between symptom profile and performance on the
summary learning measures at test was confined to a tendency to
lower expressed CI on a background of similarly reduced
excitatory learning in participants with a negative symptom
profile.
Differences by medication
There were no detectable differences by medication status: there
was no correlation between dose, measured as the CPZ equivalent,
and either inhibitory, r(21) =20.32, p=0.16, or excitatory
learning scores, r(21) =20.04, p=0.86. Neither were there any
differences in inhibitory or excitatory learning between the
schizophrenic patients on typical and atypical antipsychotics,
t(17) = 1.53, p=0.15; t(17) = 0.68, p=0.50, respectively.
Discussion
The present study demonstrated that CI was impaired in
schizophrenic compared to matched community control partici-
pants. While both groups responded similarly to the excitatory C
in compound with the neutral X, the ability of the inhibitor P to
inhibit responding to C was significantly reduced in the patient
Figure 2. Group mean rating scores for A, U, V and C in the excitatory training stage. A rating of 9 reflected expectation of a
positive image to follow, and 1 of a neutral image to follow; 5 indicated uncertainty as to the following outcome. Each block
comprised two pairings of A and C with a positive picture, and two of U and V with a neutral picture. The error bars represent two standard errors of
the mean.
Figure 3. Group mean rating scores for AZ, AP, BX and CY in the inhibitory training stage. A rating of 9 reflected expectation of a positive
image to follow, and 1 of a neutral image to follow; 5 indicated uncertainty as to the following outcome. Each block comprised four presentations of
the stimulus compounds AZ and CY paired with a positive picture, and six of compounds AP and BX paired with a neutral picture. The error bars
represent two standard errors of the mean.
doi:10.1371/journal.pone.0042175.g003
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group. Aside from the fact that P, not X, had signalled the absence
of the outcome, both stimuli had been trained identically – being
non-reinforced in the same number of compound stimulus
presentations. This difference cannot therefore be attributed to
excitatory learning at the test stage, or nonspecific effects on
performance, and is most readily interpreted as a deficit in CI.
Schizophrenic participants were also less efficient at excitatory
conditioning, responding less on reinforced trials and more on
nonreinforced trials in the training stage than the control
participants. However, this difference in excitatory learning did
not compromise our demonstration of CI deficit. Participants who
did not meet an a priori criterion for excitatory learning (5 patients
and 4 controls) were excluded, and at test there was no group
difference in responding to CX, the excitatory baseline against
which the inhibitory effect of P was assessed.
Nor was there evidence that differences in either excitatory or
inhibitory learning could be linked to medication. However, the
patient participants with higher PANSS negative scores tended to
show generally poorer excitatory and inhibitory learning.
Limitations
These conclusions rely naturally on the adequacy of our control
condition. For example, group differences in general intelligence
or motivational factors cannot be ruled out, although control
participants were, as far as possible, matched in terms of factors
such as educational level and socio-economic status. Similarly, it
was not possible to give the control participants a structured
clinical interview to rule out mental illness or substance abuse -
although behavioural differences were observed despite such
potential confounding factors. Nor was it practicable for the
experimenter to be blind to group membership, but the task was
fully automated, minimising the possibility of experimenter effects.
In addition most patients were medicated, although we did not
detect any effects of medication on either excitatory or inhibitory
learning, the numbers of participants in these analyses were
necessarily small.
Five patients were unwilling to complete the PANSS assessment
and a further 9 patients were unable to complete it on the same
day as the behavioural test. This was an exploratory analysis
intended to help identify the underlying mechanisms of any group
differences (and the available data was limited). A modest
relationship between CI and negative symptom score was
demonstrated despite the relatively small sample size and
differences in when the PANSS was administered. Excitatory
learning was similarly reduced in those with more negative
symptoms; thus CI was not selectively impaired in relation to
negative symptoms.
Impaired associative learning is often reported in schizophrenia,
in the control conditions of LI and blocking tasks [3,48], raising
the possibility that the attenuation of CI we observed is secondary
to a more general impairment in excitatory associative learning. As
a conditioned inhibitor signals the absence of an outcome
predicted by an excitatory stimulus, if earlier learning about this
excitatory stimulus is reduced, CI will be impaired. We cannot rule
out this possibility on the basis of the present data. Nonetheless,
attenuated CI in schizophrenia has not previously been demon-
strated and - even if it is related an excitatory learning deficit at the
training stage - will have effects on behaviour quite different to
those produced by a pure excitatory learning impairment.
Implications
Despite their inevitable inter-dependency, animal studies
suggest that inhibitory and excitatory learning are dissociable
[26,49], meaning that distinct neural substrates could underlie the
excitatory and inhibitory learning deficits that we observed
[31,32,50]. The demonstrated role of DA pathways in CI is
consistent with broader theories of the role of DA in learning and
specifically in mediating prediction error [32,51]. Given the
central role of DA systems in schizophrenia, prediction error
processing in schizophrenia has been extensively investigated,
largely in studies of blocking [52], in which a stimulus (B) is
conditioned in the presence of a previously trained signal for that
outcome (i.e. A+ followed by AB+). The outcome of B is already
expected, and the resultant lack of prediction error thus curtails
learning about B [48,52,53,54,55,56,57]. Participants with schizo-
phrenia [48,54,55,56,57] ‘‘incorrectly’’ condition normally to the
redundant cue, suggesting failure to compute the net prediction
error to the AB compound. Relatedly, functional magnetic
resonance imaging studies of human participants have shown that
amphetamine increases the prediction error signal in striatal
regions [58]. As learning about a conditioned inhibitor also
depends on the correct assessment of net prediction error to a
Figure 4. Group mean rating scores for C in compound with the inhibitor P and the control stimulus X in the pre-experimental and
the test stages. A rating of 9 reflected expectation of a positive image to follow, and 1 of a neutral image to follow; 5 indicated uncertainty as to the
following outcome. The error bars represent two standard errors of the mean.
doi:10.1371/journal.pone.0042175.g004
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stimulus compound, signalling the absence of the expected
outcome, a similar mechanism might underlie the CI deficit
observed here.
However, to attribute effects on learning to an abnormality in
prediction error processing is not always helpful: in simple
conditioning prediction error does not depend on stimulus novelty
- yet schizophrenic participants often show reduced conditioning
to novel cues, but enhanced conditioning to a pre-exposed CS. A
resolution to this paradox could lie in the suggestion made by some
theories of learning, that prediction error is mediated through CS
associability - ability to condition [59]. Stimuli that are pre-exposed,
or followed by a predicted outcome (e.g., the added cue in a
blocking experiment) lose associability, while stimuli followed by
surprising outcomes gain associability, but then lose it as they
become effective signals for that outcome. If the ease with which
CS associability can change were impaired in schizophrenia, this
could explain the observed pattern of results. In the blocking task,
the added cue would lose less associability when paired with the
predicted outcome, enhancing learning, while the increase in
associability normally accruing to the conditioned inhibitor, on
being paired with the unexpected absence of the outcome, would
be curtailed, reducing CI.
More broadly, our understanding of the cognitive abnormalities
accompanying schizophrenia could be advanced by an appreci-
ation of the possible role of CI. For example, sensory flooding is
frequently related to the aberrant assignment of salience - where
an irrelevant cue is treated as significant
[1,3,60,61,62,63,64,65,66,67,68]. Delusions could arise as the
patient tries to make sense of aberrantly salient experiences [12],
whereas hallucinations might reflect the anomalous salience of
internal representations. Antipsychotic drugs, acting on DA D2
receptors, could dampen the salience of these abnormal experi-
ences, alleviating symptoms [63,64]. Reduced CI could be an
additional mechanism through which salience is erroneously
attributed: Inhibitory learning allows current environmental cues
to signal that a stimulus which previously predicted an emotional
event no longer does so. Impairment in such inhibitory learning
would thus result in inappropriate responding to once valid
predictors that are currently inoperative. Casually put, irrelevant
cues would continue to be regarded as significant, and hence
salient, thus contributing to the sensory flooding and delusional
experiences characteristic of schizophrenia [1,12,67,68].
Our results demonstrate for the first time that inhibitory
learning is impaired in schizophrenia, and thus provide an
attractive framework for interpreting the positive symptoms of
schizophrenia. However, there was no evidence of any relationship
between individual variation in CI and positive symptoms as
measured by the PANSS - and participants with higher PANSS
negative scores showed relatively greater impairment, in excitatory
as well as inhibitory learning (although these data have their
limitation). We acknowledge that the deficit in inhibition we
observed could be related to an excitatory learning impairment at
the training stage. Whatever its source, a better understanding of
the relationship between CI and symptom profile may guide the
development of better targeted cognitive-behavioural interventions
for patients with schizophrenia. Accordingly the next step will be
to investigate this relationship in a larger sample with two a priori
defined sub-groups, displaying predominantly positive versus
predominantly negative symptoms.
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